STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3335 by analyst upside · 2026-06-27
MTD
Mettler-Toledo International Inc.
Healthcare · Market Cap $26B · P/E 29.2x
ANALYST PRICE TARGET
+3.8%
implied upside to consensus target
Current Price $1263.75
Consensus Target $1311.17
Bull Target $1550.0
Bear Target $1194.0
Analysts Covering 12
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
5
Hold
6
Sell
0
52-Week Low $1023.05
52-Week High $1525.17
YTD Return -10.5%
FUNDAMENTALS
Market Cap $26B
P/E Ratio (TTM) 29.2x
Forward P/E 24.6x
EPS (TTM) $43.22
PEG Ratio 2.52
Dividend Yield N/A
Revenue (TTM) $4.1B
Profit Margin 21.4%
52-WEEK RANGE
52-Week Low $1023.05
52-Week High $1525.17
Current Price $1263.75
Bear Target $1194.0
Bull Target $1550.0
● Now $1263.75 ● Target $1311.17
TRADING DATA
Avg Volume 195K
YTD Return -10.5%
Analyst Count 12
Consensus Buy
Upside to Target +3.8%
Last Updated 2026-06-27

ANALYST SUMMARY

Mettler-Toledo International Inc. (MTD) is currently trading at $1263.75 with a Wall Street consensus price target of $1311.17, implying potential upside of 3.8% over the next 12 months. 12 analysts currently cover MTD, with a consensus rating of Buy - 50% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $1550.0, while the most cautious has a target of $1194.0.

MTD operates in the Healthcare sector with a market capitalisation of $26B. The stock is down 10.5% year-to-date and is currently trading near the lower end of its 52-week range of $1023.05 – $1525.17.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for MTD, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Stifel — Reiterated
Buy → Buy 2026-05-18 Building track record
Morgan Stanley — Reiterated
Equal-Weight → Equal-Weight 2026-05-12 Building track record
JP Morgan — Reiterated
Neutral → Neutral 2026-05-11 43% win rate (7 calls)
Baird — Reiterated
Neutral → Neutral 2026-05-11 Building track record
Citigroup — Reiterated
Buy → Buy 2026-05-08 Building track record
Barclays — Reiterated
Overweight → Overweight 2026-04-14 Building track record
Evercore ISI Group — Reiterated
Outperform → Outperform 2026-04-06 Building track record
Jefferies ↑ Upgrade
Hold → Buy 2026-03-20 50% win rate (6 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
51
out of 100
Coverage depth
20/30
Consensus clarity
24/30
Vote unanimity
5/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →